Imunon, Inc. SEC filings IMNN
Imunon, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 13, 2011. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DRS | Filing | Oct 13, 2026 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2025 | — |
| EFFECT | Filing | Jun 13, 2025 | — |
| CORRESP | Letter to the SEC | Jun 11, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2025 | — |
| CORRESP | Letter to the SEC | May 30, 2025 | — |
| D | Filing | May 28, 2025 | — |
| RW | Filing | May 22, 2025 | — |
| DRS | Filing | Mar 19, 2025 | — |
| EFFECT | Filing | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| D | Filing | Aug 16, 2024 | — |
| EFFECT | Filing | May 22, 2024 | — |
| CORRESP | Letter to the SEC | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 20, 2024 | — |
| RW | Filing | Apr 10, 2024 | — |
| UPLOAD | Letter from the SEC | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| UPLOAD | Letter from the SEC | May 3, 2023 | — |
| PRER14A | Filing | Apr 12, 2021 | — |
| EFFECT | Filing | Mar 30, 2021 | — |
| CORRESP | Letter to the SEC | Mar 26, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2021 | — |
| EFFECT | Filing | Oct 27, 2020 | — |
| CORRESP | Letter to the SEC | Oct 23, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2020 | — |
| EFFECT | Filing | Aug 13, 2020 | — |
| CORRESP | Letter to the SEC | Aug 11, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2020 | — |
| EFFECT | Filing | Nov 27, 2019 | — |
| CORRESP | Letter to the SEC | Nov 26, 2019 | — |
| EFFECT | Filing | Oct 12, 2018 | — |
| CORRESP | Letter to the SEC | Oct 10, 2018 | — |
| EFFECT | Filing | Dec 8, 2017 | — |
| CORRESP | Letter to the SEC | Dec 6, 2017 | — |
| CORRESP | Letter to the SEC | Dec 1, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2017 | — |
| CORRESP | Letter to the SEC | Nov 22, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2017 | — |
| EFFECT | Filing | Aug 4, 2017 | — |
| CORRESP | Letter to the SEC | Aug 2, 2017 | — |
| RW | Form rw | Jun 16, 2017 | — |
| EFFECT | Filing | Apr 19, 2017 | — |
| CORRESP | Letter to the SEC | Apr 18, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2017 | — |
| CORRESP | Letter to the SEC | Apr 4, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2017 | — |
| EFFECT | Filing | Feb 14, 2017 | — |
| CORRESP | Letter to the SEC | Feb 13, 2017 | — |
| CORRESP | Letter to the SEC | Feb 13, 2017 | — |
| CORRESP | Letter to the SEC | Jan 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2017 | — |
| EFFECT | Filing | Nov 16, 2016 | — |
| RW | Form rw | Oct 28, 2016 | — |
| EFFECT | Filing | Sep 25, 2015 | — |
| EFFECT | Filing | Jul 30, 2015 | — |
| CORRESP | Letter to the SEC | Jul 27, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2015 | — |
| CT ORDER | Filing | Jul 7, 2015 | — |
| D | Filing | Jun 8, 2015 | — |
| EFFECT | Filing | Sep 30, 2014 | — |
| EFFECT | Filing | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 25, 2014 | — |
| CT ORDER | Filing | Sep 25, 2014 | — |
| D | Filing | Jun 24, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2014 | — |
| CT ORDER | Filing | Jun 4, 2013 | — |
| EFFECT | Filing | Sep 14, 2012 | — |
| CORRESP | Letter to the SEC | Sep 11, 2012 | — |
| CT ORDER | Filing | Aug 31, 2012 | — |
| CORRESP | Letter to the SEC | Aug 20, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2012 | — |
| EFFECT | Filing | Feb 8, 2012 | — |
| CORRESP | Letter to the SEC | Feb 7, 2012 | — |
| CORRESP | Letter to the SEC | Feb 3, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2012 | — |
| EFFECT | Filing | Sep 22, 2011 | — |
| CORRESP | Letter to the SEC | Sep 21, 2011 | — |
| CORRESP | Letter to the SEC | Sep 14, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2011 | — |
| EFFECT | Filing | Jun 24, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2011 | — |
| CORRESP | Letter to the SEC | Jun 23, 2011 | — |
| D | Filing | Jun 14, 2011 | — |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMNN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lawrenceville, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 749647
- Former names
- CELSION CORP (until Sep 19, 2022); Celsion CORP (until Sep 19, 2022); CHEUNG LABORATORIES INC (until Feb 17, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.